Medical technology company Stryker (NYSE:SYK) Monday said it executed a binding offer to acquire SERF SAS, a France-based joint replacement company. "This acquisition would complement Stryker's ...

In contrast to rival Zimmer Biomet, Stryker has diversified itself and is relatively less reliant on large joint reconstruction. The benefit of this strategy became clear as the Great Recession ...

Corin knows this to its cost. The shares , when Stryker said it would suspend deliveries of Corin's Cormet hip replacement technolgy, and this latest development leaves investors in the UK company in ...

In contrast to rival Zimmer Biomet, Stryker has diversified itself and is relatively less reliant on large joint reconstruction. The benefit of this strategy became clear as the Great Recession ...

Stryker Corp. is a medical technology company ... The Orthopaedics and Spine segment focuses on implants used in hip and knee joint replacements and trauma and extremity surgeries, and cervical ...